I have comprehensive content from multiple authoritative textbooks. Let me now compile the complete note on Neurocysticercosis.
Neurocysticercosis (NCC) - Short Note
Etiology
Neurocysticercosis is the most common parasitic disease of the CNS worldwide and the leading cause of symptomatic epilepsy globally.
- Causative organism: Larval stage (cysticercus) of Taenia solium (pork tapeworm)
- Transmission: Humans become accidental intermediate hosts by ingesting food or water contaminated with T. solium eggs (feco-oral route), or via autoinfection from a tapeworm carrier (eggs attach to hands, transmitted orally)
- After ingestion, ova hatch in the gut, releasing oncospheres which invade the intestinal wall, migrate hematogenously, and lodge in the CNS (as well as muscle, eye, subcutaneous tissue)
- Endemic regions: Latin America, India, sub-Saharan Africa, Southeast Asia
(Bradley and Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine, 22E)
Clinical Features
- Seizures - the most common presentation; new-onset partial seizures with or without secondary generalization (explains up to 29% of new-onset epilepsy in endemic areas)
- Headache and raised intracranial pressure (ICP) - from hydrocephalus when cysts obstruct CSF flow in ventricles or subarachnoid space
- Focal neurological deficits - depending on cyst location in parenchyma
- Meningitis/encephalitis - when heavy infestation triggers diffuse inflammatory response
- Sudden death - possible with intraventricular cysts causing acute obstructive hydrocephalus
- Spinal cysticerci can mimic intraspinal tumors
Symptoms arise largely from the host's inflammatory response as the cyst degenerates and dies - not from the live parasite itself. Eventually after cyst death (process taking several years), seizures often abate.
(Harrison's, 22E; Tintinalli's Emergency Medicine)
Neuroimaging Findings
This is a staging-based diagnosis. Four stages are recognized, each with distinct CT/MRI appearances:
Stage 1 - Vesicular Stage (Live cyst)
- Cyst contains viable larva with an invaginated scolex
- MRI: Well-defined cystic lesion with a small eccentric nodule (scolex) - the classic "hole-with-dot" sign (cyst + scolex)
- No significant perilesional edema
- No surrounding enhancement
- Fluid isointense to CSF on all sequences
Stage 2 - Colloidal Stage (Degenerating cyst)
- Host immune response begins as larva degenerates
- MRI: Ring or peripheral enhancement on post-contrast images
- Substantial surrounding edema on T2/FLAIR images
- Cyst contents become turbid (hyperintense to CSF on T1)
Stage 3 - Granulonodular Stage
- Cyst shrinks, scolex mineralizes
- MRI post-contrast: Homogeneous solid nodular enhancement (no central cyst cavity)
- No surrounding edema on FLAIR
- Lesion is smaller and more solid
Stage 4 - Nodular-Calcified Stage (Dead/burnt-out)
- Cyst completely dies and calcifies
- CT: Best modality - shows punctate parenchymal calcifications (most common finding overall)
- MRI: Calcifications can be difficult to detect; susceptibility-weighted imaging (SWI) is the most sensitive MRI sequence for these small calcific foci
- No enhancement, no edema
Key teaching point: Multiple lesions at different stages may coexist simultaneously in the same patient - active enhancing lesions, ring-enhancing cysts with edema, and calcified "burnt-out" lesions all visible together.
Special Forms on Imaging
| Form | Imaging Features |
|---|
| Leptomeningeal/Basal | Soft tissue filling basal cisterns with marked contrast enhancement; granulomata with variable calcification in subarachnoid space |
| Intraventricular | Cyst within ventricle (may be isointense to CSF, easy to miss on CT); MRI superior for detecting cyst + scolex; risk of acute hydrocephalus |
| Racemose | Multilobular cysts without a scolex in subarachnoid space; typically in cerebellopontine angles, suprasellar region, basal cisterns, and Sylvian fissures; may enhance |
| Complications | Hydrocephalus, brain infarcts (from vasculitis), meningeal enhancement |
MRI vs CT: MRI is superior for detecting intraventricular cysts and the scolex; CT is better for calcifications.
(Grainger & Allison's Diagnostic Radiology; Harrison's Principles of Internal Medicine, 22E)
Management
Treatment is individualized based on the number, location, viability, and stage of cysts.
1. Antiparasitic (Anthelminthic) Therapy
| Scenario | Treatment |
|---|
| Parenchymal viable/enhancing (1-2 cysts) | Albendazole monotherapy + steroids |
| Parenchymal viable/enhancing (>2 cysts) | Albendazole + Praziquantel + steroids |
| Calcified cysts (any number) | No antiparasitic treatment (parasite already dead) |
| Encephalitis / diffuse cerebral edema | No antiparasitic treatment - steroids only |
- Standard dose: Albendazole 15 mg/kg/day (in 2 divided doses) x 8-28 days; Praziquantel 50-100 mg/kg/day x 15-30 days
2. Corticosteroids
- Used to control the inflammatory response triggered by dying parasites
- Dexamethasone or prednisolone - mandatory when using antiparasitic drugs to reduce edema and seizure risk
3. Antiepileptic Drugs (AEDs)
- Seizures are typically controlled with antiepileptic monotherapy
- AEDs are first-line for symptomatic seizures regardless of cyst stage
4. Surgical / Interventional
| Scenario | Approach |
|---|
| Intraventricular (lateral or 3rd ventricle) | Neuroendoscopic removal (preferred) |
| 4th ventricle cyst | Neuroendoscopic or microsurgical removal |
| Removal not feasible | Ventricular shunt first, then antiparasitic + steroids |
| Subarachnoid (extraparenchymal) | Ventricular shunt if hydrocephalus, then prolonged albendazole ± praziquantel |
| Hydrocephalus with no visible cysts | Ventricular shunt only; no antiparasitic treatment |
| Ocular cysticercosis | Surgical resection of cysts |
| Spinal cysticercosis | Surgical removal or antiparasitic + steroids (individualized) |
5. Diagnosis Confirmation (if needed)
- Enzyme-linked immunotransfer blot (EITB) is the recommended serological confirmatory test
- Fundoscopy is recommended for all suspected cases (to rule out ocular involvement before starting antiparasitic therapy - treatment can cause inflammatory damage to the eye if cysts are present)
(Bradley and Daroff's Neurology - Table 79.7, adapted from IDSA/ASTMH 2017 Clinical Practice Guidelines; Harrison's 22E; Tintinalli's)
Sources:
- Harrison's Principles of Internal Medicine, 22E (McGraw Hill, 2025)
- Grainger & Allison's Diagnostic Radiology
- Bradley and Daroff's Neurology in Clinical Practice
- Tintinalli's Emergency Medicine
- Goldman-Cecil Medicine